Neurospora intermedia is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Neurospora Intermedia.
| Product ID | 49288-0326_272c9910-2160-4d41-afbd-faab3055ba1d |
| NDC | 49288-0326 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Neurospora intermedia |
| Generic Name | Neurospora Intermedia |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1974-03-23 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102223 |
| Labeler Name | Antigen Laboratories, Inc. |
| Substance Name | NEUROSPORA INTERMEDIA |
| Active Ingredient Strength | 0 g/mL |
| Pharm Classes | Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 1974-03-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1974-03-23 |
| Inactivation Date | 2019-10-21 |
| Ingredient | Strength |
|---|---|
| NEUROSPORA INTERMEDIA | .05 g/mL |
| SPL SET ID: | 6d2006e2-55ea-41db-bd17-ce6d080f28a0 |
| Manufacturer | |
| UNII |
|
| RxNorm Concept Unique ID - RxCUI | |
| Pharm Class PE | |
| PHarm Class EPC | |
| NUI Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0268-0916 | NEUROSPORA INTERMEDIA | NEUROSPORA INTERMEDIA |
| 0268-0917 | NEUROSPORA INTERMEDIA | NEUROSPORA INTERMEDIA |
| 0268-0918 | NEUROSPORA INTERMEDIA | NEUROSPORA INTERMEDIA |
| 0268-0919 | NEUROSPORA INTERMEDIA | NEUROSPORA INTERMEDIA |
| 0268-0920 | NEUROSPORA INTERMEDIA | NEUROSPORA INTERMEDIA |
| 0268-6538 | NEUROSPORA INTERMEDIA | Neurospora spp |
| 0268-6539 | NEUROSPORA INTERMEDIA | Neurospora spp |
| 22840-1699 | Neurospora intermedia | Neurospora intermedia |
| 22840-2600 | Neurospora intermedia | Neurospora intermedia |
| 22840-2601 | Neurospora intermedia | Neurospora intermedia |
| 22840-2602 | Neurospora intermedia | Neurospora intermedia |
| 22840-5627 | Neurospora intermedia | Neurospora intermedia |
| 36987-2011 | Neurospora intermedia | Neurospora intermedia |
| 36987-2017 | Neurospora intermedia | Neurospora intermedia |
| 36987-2014 | Neurospora intermedia | Neurospora intermedia |
| 36987-2012 | Neurospora intermedia | Neurospora intermedia |
| 36987-2013 | Neurospora intermedia | Neurospora intermedia |
| 36987-2018 | Neurospora intermedia | Neurospora intermedia |
| 36987-2015 | Neurospora intermedia | Neurospora intermedia |
| 36987-2010 | Neurospora intermedia | Neurospora intermedia |
| 36987-2016 | Neurospora intermedia | Neurospora intermedia |
| 49288-0326 | Neurospora intermedia | Neurospora intermedia |